rates to hospital volume, or surgeon number, and show that there is a pressing need to design lung cancer services which enable all patients, including those first seen at non-surgical centres, to have equal access to lung cancer surgery.
INTRODUCTION
Non-small cell lung cancer (NSCLC) accounts for almost 85% of all lung cancer cases diagnosed in England, [1, 2] and for these people surgical resection offers the best chance for cure and long term survival. [3, 4] Compared with other European countries and North America, England has poor overall survival and lower resection rates. [5, 6] Patients with stage I or II disease, who are a minority of those diagnosed, are believed to benefit from surgical resection. [4, 7] In a previous study we have shown that patients first seen at a surgical centre were more likely to have surgery than patients who were not first seen in a surgical centre. [3] In addition, patients have a better survival if their operation is in a high volume surgical centre. [1] The National Lung Cancer Audit (NLCA) commissioned by the Healthcare Quality Improvement Partnership (HQIP) was established in 2004 to measure the quality of services provided by National Health Service (NHS) hospitals to patients with lung cancer in order to improve outcomes. [3, 4] There are 157 NHS centres, of which 30 centres offer thoracic surgery and have a thoracic or cardiothoracic surgeon on site. Almost all patients with lung cancer are discussed by the multidisciplinary team (MDT) at each centre where they are first seen, with thoracic surgeons attending in person or via video conferencing from the 30 centres where thoracic surgical operations are performed (here after referred to as 'surgical centres'). Thus a surgical centre's catchment population is considerably larger than that of an individual NHS centre and it is possible that the size of this catchment population and the lung cancer burden that comes with it could influence access to surgery. To date there have been no studies quantifying the catchment population or assessing whether the size of the lung cancer catchment population is related to an individual patient's likelihood of having surgery.
We used data from the NLCA database linked with the Hospital Episode Statistics (HES) inpatient data from 2008 to 2012 to quantify the impact of individual patient features and size of surgical centre lung cancer catchment population on the likelihood of having surgery for NSCLC.
METHODS

Database
The validated NLCA database [8] 
Study population
We conducted a cross-sectional analysis and used data on all patients in the NLCA who were first diagnosed 
Surgical centre lung cancer catchment population
In England, people with lung cancer are operated on at one of the 30 thoracic surgical centres, which have thoracic or cardiothoracic surgeons on site, who perform all lung cancer resections. To calculate a catchment population representing the total number of patients with lung cancer that a surgical centre is responsible for, we used data on the distribution of surgically resected patients between surgical centres and the total number of lung cancer patients first seen at each of the 157 centres. For 128 centres (80%), all of their resected patients were operated on at a single surgical centre and so all lung cancer patients (whether they had surgery or not) from these centres were allocated to the catchment population of that surgical centre. Where a centre had patients who were operated on at more than one surgical centre, their total number of lung cancer patients were allocated to each of these centres' catchment population in the same ratio as the operated patients. Using this method, all the patients with NSCLC, including the non-operated patients, were allocated to the catchment population of one of the 30 surgical centres in England to derive a 'lung cancer catchment population'.
The annual lung cancer patient catchment population for each surgical centre was calculated and categorised as follows: <400 patients/year (7 centres), 400 to 700 patients/year (7 centres), 700 to 1100 patients/year (9 centres) and >1100 patients/year (7 centres). This division of the surgical centres, was done in order to create quartiles with an almost equal number if surgical centres. We also 
Statistical analysis
All data and statistical management were performed using Stata version 12 (StataCorp, USA). We used multivariate logistic regression analyses to estimate the odds of having surgery (odds ratios (ORs)) by patient and surgical centre features. We also performed a sensitivity analysis by restricting our dataset to patients with stage I and II NSCLC.
We used logistic regression analyses to estimate odds of having surgery for patients first seen in a surgical centre verses patients first seen in a non-surgical centre. We looked for interaction between where the patient was first seen and the surgical centre lung cancer catchment population.
Pearson correlation analysis was used to quantify the relationship between the surgical centre catchment population and number of surgeons on site.
RESULTS
Our dataset consisted of 120,050 patients who were diagnosed with lung cancer between 1 st January 2008 and 31 st March 2012. We excluded 20,398 (17%) patients who were diagnosed as having smallcell lung cancer, mesothelioma or carcinoid tumours; and 554 (0.4%) patients for whom we could not generate a start date. We excluded a further 2,555 (2%) patients who did not have information on centre of diagnosis (or centre of surgery if they had a surgical resection) and 725 (0.6%) patients who could not be redistributed to one of the 30 surgical centres due to miscoding. Therefore our analysis was based on 95,818 patients. The median age at diagnosis was 72 years (interquartile range 64 -79), 64% (n=54,074) of the patients were male, 42% (n=40,302) were categorised as PS 0 or 1 and 41% (n=39,505) had stage IV disease. Thirteen per cent (n=12,759) of our cohort had a record of surgery in either HES or NLCA. Surgical centre catchment population for lung cancer patients
Basic description
The seven surgical centres with the smallest lung cancer catchment populations covered only 8% of the national burden of lung cancer patients (Table 2) , however in these centres the proportion of patients resected was slightly higher (14.8%) than that in the centres with larger lung cancer catchment populations (12.3%, 13.5% & 13.2% respectively) and this difference was on the borderline of statistical significance (log-likelihood p-value = 0.06). In the smallest lung cancer catchment population group, 59% of patients were first seen in a surgical centre compared with only All the surgical centres with the smallest lung cancer catchment population had 3 or fewer surgeons on-site, while only 1 of the 7 surgical centres with the largest lung cancer catchment population had more than 5 surgeons on-site. There was also no association seen between the number of cardiothoracic surgeons on site and the likelihood of having surgery (p-value = 0.88).
Resection in patients first seen at a surgical centre compared with those first seen at a nonsurgical centre
We divided patients into those who were first seen and managed by a surgical centre and patients who were first seen in non-surgical centres. Surgical centres with a large catchment population were observed to have a higher resection rate on patients first seen in their own centre, compared with those patients first seen in a non-surgical centre in the surrounding area, and served by the same surgical centre (figure 2). 
Sensitivity analysis for stage I & II
DISCUSSION
Our results demonstrate that the likelihood of having surgery for patients with NSCLC is independently influenced by patient features including age, sex, stage, performance status and comorbidity which are all part of clinically appropriate case selection. The likelihood of having surgery is also influenced by surgical centre features, most notably the surgical centre lung cancer catchment population. It was observed that as the lung cancer catchment population of surgical centres increases, the centre is more likely to operate on patients first seen 'in house' and less likely to operate on patients first seen at the non-surgical centres, even though this group of patients represents 75% of the total lung cancer population overall and 85% of the patients for the centres with the large catchment population size. The same association was seen when we restricted our analyses to histologically proven cases only (data not shown).
Strengths and limitations
This study utilises a large dataset and its representative nature gives a true reflection of the diagnosis, treatment and management of patients with NSCLC in England. Although the data entry into the NLCA is non-mandatory, previous studies have shown that the missing data are unbiased. [4] As an added measure, for this study we used only data from 2008 onwards, when the NLCA case ascertainment achieved a level of more than 90%. [9, 10] Unlike studies which utilise large cancer registry data, [5, 12, 13] our linked dataset provides more information on co-morbidity and PS allowing for better case-mix adjustment. We used a valid measure of co-morbidity, the Charlson Index using the HES database which has shown coding accuracy of 91%. [14] The linked HES and NLCA database also allowed us to identify about 4% more surgically resected patients which would have been missed by using the NLCA data alone. [15] We utilised strict criteria to identify patients who had complete data on surgical centre and excluded 2,500 patients who had surgery but incomplete accompanying data i.e. missing data on centre first seen or centre where patient had surgery. It is unlikely that these exclusions will have introduced bias as we have no reason to suspect that any one surgical centre had more missing data than the others.
We used number of cardiothoracic surgeons for 2010 only, but this is likely to be representative as it falls in the middle of the timeframe of our patient cohort. It was not possible to distinguish between operations performed by cardiothoracic surgeons compared with pure thoracic surgeons. Previous studies have reported that higher resection rates, better survival and the ability to handle complex operations are associated with specialist thoracic surgeons. [16] [17] [18] In addition, there could be other features of a surgical centre e.g. time to decision (for surgery), MDT composition and the number of lung cancer nurse specialists which may influence the timing of decisions and even patient willingness to undergo surgical resection.
Comparison with other studies
The findings in this study are in agreement with the observation from previous studies utilising UK and European databases; females are more likely to have surgery and have a better prognosis compared with males, [1, 2] while increasing age, co-morbidity, worsening PS and advanced stage disease were all unfavourable factors for having surgery and survival. [3, 4, 19] A previous study utilising the NLCA database by Rich et al [3] showed an increased odds (OR=1.51) of having surgery if the patient is first seen in a surgical centre, which were similar to our study, however our study is the first to identify odds of having surgery based on the lung cancer catchment population of a surgical centre. In addition, we were also able to show a significant trend association between socioeconomic status and odds of having surgery, mainly due to a more complete dataset than the previous study.
Previous studies in the UK have highlighted geographical inequality in diagnosis and treatment based on where the patient is first seen and managed, [1, 3, 20, 21] while there are contrasting studies regarding hospital volume and survival. [22] [23] [24] Lau et al, [16] showed that increasing the number of cardiothoracic surgeons increased the resection rate of the centre, which is also seen in our study.
However, our results would suggest that this increase would preferentially benefit 'in house' patients rather than patients first seen in a non-surgical centre. Lau et al also found no correlation between resection rates and annual number of NSCLC cases seen in all surgical and non-surgical centres (Pearson's correlation co-efficient = 0.0017). However we believe our results are more accurate as our data are not derived from surgical centres alone.
Clinical Relevance
This study has identified an inequality in lung cancer care provision. Surgical centres with large catchment populations have more surgeons to address the lung cancer burden, but are unable to provide equal access to surgery for patients seen at the non-surgical centres they serve, compared with patients presenting to their own centre. Our study is the first of its kind to look at the catchment population a surgical centre is responsible for, and to test the 'hub and spoke model'. Ideally this model, with surgical centres drawing patients from surrounding centres allows the NHS to accurately redistribute its resources and manpower according to need in order to create equality in lung cancer care. Our study has highlighted the key role that the surgical centres with large catchment populations can play in improving the surgical resection rates in England, and the need to provide equal access to this service.
Contributionship Statement
The conception of the study was done by RBH, ALR and RAS. AK acquired the data from the HSCIC and all analysis was done by AK. RBH and ALR were involved in the data interpretation. Majority of the paper (including the initial draft) was written by AK. HAP, LJT, RAS, JPD, DRB, ALR and RBH were involved revising the paper critically. This final manuscript was approved by all the authors prior to submission.
Ethics
The 
